SEC-sourced researchBeta
TNDM
TANDEM DIABETES CARE INC
Company comparison ↗
Data passport
- CIK
- 0001438133
- Exchange
- Nasdaq
- Business activity
- — · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Sep 17, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 747,718,000.0000 | Feb 19, 2026 |
| December 2024 | 940,203,000.0000 | Feb 19, 2026 |
| December 2025 | 1,014,736,000.0000 | Feb 19, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,014,736,000.0000 | -204,710,000.0000 | -9,721,000.0000 | 881,112,000.0000 | 725,942,000.0000 | Feb 19, 2026 |
| December 2024 | 940,203,000.0000 | -96,025,000.0000 | 24,225,000.0000 | 967,658,000.0000 | 704,560,000.0000 | Feb 19, 2026 |
| December 2023 | 747,718,000.0000 | -222,611,000.0000 | -31,810,000.0000 | — | — | Feb 19, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.01B | December 2025 | Feb 19, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $940.2M | December 2024 | Feb 19, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$204.71M | December 2025 | Feb 19, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$9.72M | December 2025 | Feb 19, 2026 | 10-K |
| Total assetsAssets | $881.11M | December 2025 | Feb 19, 2026 | 10-K |
| Total liabilitiesLiabilities | $725.94M | December 2025 | Feb 19, 2026 | 10-K |